Central Anticholinergic Adverse Effects and Their Measurement

Area of Science:

• Pharmacology
• Geriatrics
• Clinical Toxicology

Background:

• Anticholinergic drugs are widely prescribed but cause adverse reactions, particularly central effects in the elderly.
• Many drugs possess anticholinergic properties, increasing the risk of side effects beyond 'pure' anticholinergics.
• Monitoring anticholinergic drug effects and serum concentrations presents significant challenges.

Purpose of the Study:

• To investigate the central anticholinergic effects of various drugs.
• To evaluate the utility of the serum anticholinergic assay (SAA) in predicting anticholinergic effects.

Main Methods:

• Review of existing literature on anticholinergic drug effects on cognition.
• Analysis of studies utilizing the serum anticholinergic assay (SAA) to measure anticholinergic burden.

Main Results:

• Research on anticholinergic drug effects on cognition yields mixed results, potentially due to population, drug, and clinical condition variations.
• The serum anticholinergic assay (SAA) provides variable results and does not consistently correlate with patient medication.
• SAA levels may not accurately reflect the actual anticholinergic burden experienced by patients.

Conclusions:

• The clinical significance of central anticholinergic effects requires further investigation.
• The reliability and clinical utility of the serum anticholinergic assay (SAA) in predicting anticholinergic adverse reactions are questionable.
• Strategies to minimize unnecessary anticholinergic drug exposure, especially in vulnerable populations, are crucial.